HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Miralem Pasic Roland Hetzer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yankah, A. C. Articles by Hetzer, R. Search for Related Content PubMed PubMed Citation Articles by Yankah, A. C. Articles by Hetzer, R. Related Collections Valve disease

Eur J Cardiothorac Surg 2005;28:69-75
© 2005 Elsevier Science NL

Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study

Deutsches Herzzentrum Berlin, Germany

Received 15 November 2004; received in revised form 11 March 2005; accepted 14 March 2005.

^* Corresponding author. Address: German Heart Institute, Humboldt Medical University, Augustenburger Platz 1, D-13353 Berlin, Germany. Tel./fax: +49 30 45932021. (Email: yankah{at}dhzb.de).

Objective: The study was conducted to evaluate the long-term results of homograft reconstruction of the left ventricular outflow tract with a cryopreserved aortic homograft in the presence of aortic root abscess associated with a biofilm bacterial infection. Methods: Between January 1987 and December 2003, 161 patients with aortic root abscess underwent freehand aortic valve (FAVR, N=78) and aortic root replacement (ARR, N=83) with an antibiotic treated cryopreserved aortic homograft. Their mean age was 53.1±15.6 years. Endocarditis of the native valve was found in 80 patients and of the prosthetic valve in 81; of the prosthetic valves 49 (60.5%) were mechanical and 32 (39%) bioprosthetic. Aortic ventricular discontinuity was found in 83 patients. The common responsible microorganisms were the biofilm bacteria: Staphylococcus (S. epidermidis: 34, S. aureus: 13) in 47 patients followed by Enterococcus in 23 and Streptococcus in 39. Surgery was urgent in 80 patients and emergent in 81, of whom 44 were in cardiogenic shock. Follow-up totaled 810.8 patient-years (mean: 5.0±4.3 years) and was 100% complete. Results: Operative mortality was 9.3% for elective/urgent and 14.3% for emergency surgery. A total of 7.3% patients died after hospital discharge during the 17-year follow-up period. The actuarial patient survival at 17 years was 70.4±3.6%. Early and late residual/recurrent infections and paravalvular leaks occurred in 4.3 and 2.5%, respectively. Reoperations were carried out in 30 patients, 11 for residual/recurrent infection and paravalvular leaks. Twenty-one patients with FAVR and 9 with ARR techniques underwent reoperation. Early reoperation rate was 4.3%. The actuarial freedom from residual/recurrent infection and paravalvular leaks was 91.6±2.4%. Actuarial freedom from reoperation at 17 years was 75±3.7%. It was 82.9±5.5% for ARR and 63.5±6.7% for AAVR technique. The actuarial freedom from structural valve deterioration (SVD) at 17 years was 98.6±0.4.% at a rate of %/patient-year. Conclusions: Radical debridement of the infected aortic root and homograft ARR offer a low recurrent infection rate and an overall low valve-related morbidity and mortality for up to 17 years. The antibiotic permeable cryopreserved homograft has proven to be resistant to biofilm bacterial infection.

Key Words: Biofilm bacterial endocarditis • Aortic root abscess • Homograft aortic root replacement

This article has been cited by other articles:

				L. M. Fedoruk, W. R. E. Jamieson, H. Ling, J. S. MacNab, E. Germann, S. S. Karim, and S. V. Lichtenstein Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 326 - 333. [Abstract] [Full Text] [PDF]

				E. R. Nowicki, G. B. Pettersson, N. G. Smedira, E. E. Roselli, E. H. Blackstone, and B. W. Lytle Aortic Allograft Valve Reoperation: Surgical Challenges and Patient Risks Ann. Thorac. Surg., September 1, 2008; 86(3): 761 - 768. [Abstract] [Full Text] [PDF]

				M. Musci, H. Siniawski, M. Pasic, Y. Weng, A. Loforte, S. Kosky, C. Yankah, and R. Hetzer Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh(R) stentless bioprosthesis Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 410 - 417. [Abstract] [Full Text] [PDF]

				A. Saito, N. Motomura, K. Kakimi, K. Narui, N. Noguchi, M. Sasatsu, K. Kubo, Y. Koezuka, D. Takai, S. Ueha, et al. Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2,3-dioxygenase in a murine model J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 159 - 167. [Abstract] [Full Text] [PDF]

				G. Krasopoulos, T. E. David, and S. Armstrong Custom-tailored valved conduit for complex aortic root disease J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 3 - 7. [Abstract] [Full Text] [PDF]

				T. E. David Surgical Treatment of Aortic Valve Endocarditis Card. Surg. Adult, January 1, 2008; 3(2008): 949 - 956. [Full Text]

				S. Chocron, D. Buklas, C. Taberlet, D. Kaili, P. E. Falcoz, and J.-P. Etievent Monobloc Aorto-Mitral Homograft: Report of Two Cases Ann. Thorac. Surg., October 1, 2007; 84(4): e14 - e16. [Abstract] [Full Text] [PDF]

				M. Musci, H. Siniawski, M. Pasic, O. Grauhan, Y. Weng, R. Meyer, C. A. Yankah, and R. Hetzer Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 118 - 125. [Abstract] [Full Text] [PDF]

				C. A. Mestres and J. M. Miro Editorial comment: Allograft aortic root replacement in complex prosthetic valve endocarditis Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 131 - 132. [Full Text] [PDF]

				T. E. David, T. Regesta, G. Gavra, S. Armstrong, and M. D. Maganti Surgical treatment of paravalvular abscess: long-term results Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 43 - 48. [Abstract] [Full Text] [PDF]

				T. E. David, G. Gavra, C. M. Feindel, T. Regesta, S. Armstrong, and M. D. Maganti Surgical treatment of active infective endocarditis: A continued challenge J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 144 - 149. [Abstract] [Full Text] [PDF]